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Quiescence is required for the maintenance of hema-
topoietic stem cells (HSCs). Members of the Cip/Kip
family of cyclin-dependent kinase (CDK) inhibitors
(p21, p27, p57) have been implicated in HSC quies-
cence, but loss of p21 or p27 in mice affects HSC
quiescence or functionality only under conditions of
stress. Although p57 is the most abundant family
member in quiescent HSCs, its role has remained un-
characterized. Here we show a severe defect in the
self-renewal capacity of p57-deficient HSCs and a
reduction of the proportion of the cells in G0 phase.
Additional ablation of p21 in a p57-null background
resulted in a further decrease in the colony-forming
activity of HSCs. Moreover, the HSC abnormalities
of p57-deficient mice were corrected by knocking
in the p27 gene at the p57 locus. Our results therefore
suggest that, among Cip/Kip family CDK inhibitors,
p57 plays a predominant role in the quiescence and
maintenance of adult HSCs.
INTRODUCTION
Progression of the cell cycle is controlled by pairs of cyclins and
cyclin-dependent kinases (CDKs). Progression throughG1phase
of the cell cycle is dependent on the cyclin D-CDK4 (or CDK6)
complex, whereas cyclin E-CDK2 is required for the G1-S transi-
tionandcyclinsAandB togetherwithCDK1are required forG2-M
progression (Sherr and Roberts, 2004). Cell cycle progression is
also under the control of negative regulators, the CDK inhibitors
(CKIs), which belong to either the Ink4 or Cip/Kip families.
Members of the Ink4 family—such as p16Ink4a, p15Ink4b,
p18Ink4c, and p19Ink4d—are inhibitors specific for CDK4 or
CDK6, whereas those of the Cip/Kip family, including p21Cip1
(p21), p27Kip1 (p27), and p57Kip2 (p57), mainly target CDK2 and
CDK4 (and CDK1 in some situations) for inhibition.
Sustained hematopoiesis in adults requires preservation of a
quiescent, multipotential hematopoietic stem cell (HSC) pool
that intermittently yields progenitors with robust proliferative
potential (Arai and Suda, 2007). In contrast, the cell cycle of262 Cell Stem Cell 9, 262–271, September 2, 2011 ª2011 Elsevier InHSCs is active during embryogenesis in order to ensure expan-
sion of the stem cell pool (Pawliuk et al., 1996). The ability of adult
HSCs to reside in the quiescent state has been thought to be
pivotal for maintenance of their ‘‘stemness.’’ However, the
precise mechanisms by which such quiescence is established,
maintained, and terminated have been largely unknown. CKIs
including p21, p27, and p57 are implicated in the maintenance
of quiescence, given their function to antagonize CDK activity
that promotes cell proliferation. However, self-renewal of HSCs
in mice deficient in p21 was found to be impaired only under
stressful conditions in which DNA is damaged by exposure to
5-fluorouracil or g-irradiation (Cheng et al., 2000b; van Os et al.,
2007). Deletion of p27 in mice also does not affect the number,
cycling, or self-renewal of HSCs (Cheng et al., 2000a). Although
many studies have suggested the importance of p57 for mainte-
nance of HSC stemness (Miyamoto et al., 2007; Qian et al., 2007;
Yamazaki et al., 2006), the role of p57 in control of HSC quies-
cence has remained poorly characterized. Unlike p21- or
p27-deficient mice, mice lacking p57 die immediately after birth,
manifesting severe developmental defects (Takahashi et al.,
2000; Yan et al., 1997; Zhang et al., 1997), which has rendered
functional characterization of their HSCs technically difficult.
We have now established mice in which the p57 gene is
conditionally disrupted in the hematopoietic system in order to
avoid the neonatal mortality of conventional p57-deficient
mice. Deletion of p57 alone, but not that of p21 or p27, resulted
in a reduction in HSC number, in the size of the G0 population,
and in their reconstitution ability after transplantation. Mice lack-
ing both p21 and p57 showed a more severe phenotype than
those lacking p57 alone, and knockin of the gene for p27 at the
p57 locus corrected the abnormalities of p57-deficient mice,
suggestive of functional overlap between p57 and either p21 or
p27. Our data thus indicate that p57 plays the dominant role
among CKIs of the Cip/Kip family in maintenance of quiescence
and stemness of HSCs.
RESULTS
p57 Is Predominantly Expressed in the Long-Term
HSC Population
A previous study suggested that, among hematopoietic cells,
p57 mRNA is most abundant in CD34–c-Kit+Sca-1+ lineage
marker-negative (Lin–) HSCs (CD34–KSL HSCs), a fraction withc.
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trast, p21 mRNA was not detected in CD34–KSL HSCs, whereas
p27 mRNA was found to be present in both CD34–KSL and
CD34+KSL cells, the latter corresponding to a fraction with
short-term repopulating capacity. To examine the expression
of p57 in HSCs at the protein level, we performed immunoblot
analysis of sorted bone marrow (BM) samples from 12 wild-
type mice at 8 weeks of age. We sorted and fractionated KSL
cells with the SLAM (signaling lymphocytic activation molecule)
marker CD150. Similar to the pattern observed for its mRNA,
p57 protein was most abundant in the CD150+KSL fraction, a
fraction with long-term repopulating capacity; it was present in
smaller amounts in the CD150–KSL fraction, a fraction with
short-term repopulating capacity, and it was not detected in
other fractions (Figure 1A). We did not detect p21 in any of the
fractions tested, whereas p27 was expressed at a low level in
the CD150+KSL and CD150–KSL populations. These patterns
of protein expression prompted us to examine the effects of
p57 ablation in HSCs.
Deletion of p57 Leads to a Reduction in Size
of the HSC Population
Given that most conventional p57 knockout mice die during the
perinatal period as a result of respiratory distress, probably
caused by skeletal anomalies (Takahashi et al., 2000; Yan
et al., 1997; Zhang et al., 1997), it has been technically difficult
to characterize adult HSCs in such mice. We therefore estab-
lishedmouse embryonic stem cells (ESCs) that harbor a ‘‘floxed’’
p57 allele in which exons 2 to 4 (which include the entire coding
region) are flanked by loxP sites (see Figure S1A available on-
line). This allele was generated by homologous recombination
followed by transient transfection of the ESCs with a vector for
Cre recombinase in order to remove the introduced neo cassette
(Figure S1B). Mice heterozygous for the floxed allele (p57+/F
mice) were generated by microinjection of the mutant ESCs
into blastocysts and breeding of the resultant chimeric animals
with mice of the C57BL/6 strain. The p57 locus undergoes
genomic imprinting, with only the maternal allele being ex-
pressed (Matsuoka et al., 1995). The p57+/F mice were indistin-
guishable from wild-type animals, confirming that the floxed
allele is functional. We also confirmed that the phenotype of
mice in which the maternal floxed allele was deleted by Cre
recombinase expressed from the EIIa gene promoter (Lakso
et al., 1996) beginning early during embryogenesis was identical
to that of conventional p57 knockout mice (Figure S1C). To
ablate the maternal p57 allele only in the hematopoietic system,
we crossed female p57+/F mice with male mice harboring a Cre
transgene under the control of the promoter for the myxovirus
resistance 1 (Mx1) gene. We confirmed that almost all floxed
alleles were inactivated by Cre recombinase in BM of Mx1-
Cre/p57+/F mice after intraperitoneal injection of poly(I)-poly(C)
[poly(I:C)] to activate the Mx1 gene promoter (Figure S1D).
Without poly(I:C) injection, a slight decrease in the abundance
of p57 mRNA was observed in Mx1-Cre/p57+/F mice compared
with that in Mx1-Cre/p57+/+ mice. Deletion of the p57 allele
resulted in a small increase in the amounts of p27 and p18
mRNAs in KSL cells, whereas deletion of p21 or p27 did not
significantly affect the abundance of mRNAs for the correspond-
ing other two CKIs (Figures S1E–S1H).CellAs early as 4 weeks after poly(I:C) injection, a substantial
reduction in the size of theKSL fractionwas apparent in p57-defi-
cient mice compared with that in control littermates (Mx1-Cre/
p57+/+ mice), which were also injected with poly(I:C) to exclude
the possibility that poly(I:C) affected phenotype regardless of
genotype (Figure 1B). This reduction in the size of theKSL fraction
in p57-deficient mice was apparent for all KSL subpopulations
examined (CD150–, CD150+CD48–, CD34–, or CD34+ cells) with
the exception of CD150+CD48+ cells (Figure 1C). The total
number and composition of cells in BM or peripheral blood
were not otherwise affected by deletion of p57 at 4 weeks
(Figures S1I–S1K and data not shown) or 4 months (Figure S1L
and data not shown) after injection of poly(I:C), probably in part
because the effect of such deletion in adult HSCs was compen-
sated for at later stages of differentiation or had not had sufficient
time to becomemanifest in the periphery within the period before
analysis. In contrast, no reduction in the size of the HSC popula-
tion was observed in p21- or p27-deficient mice (Figure 1C),
consistent with the results of previous studies (Cheng et al.,
2000a, 2000b; vanOset al., 2007). Thesefindings thus suggested
that p57 deletion affects the self-renewal capacity of HSCs.
Deletion of p57 Abrogates the Self-Renewal Capacity
of HSCs
To assess the repopulating capacity of p57-deficient HSCs
in vivo, we performed a competitive reconstitution assay in
which BM cells (4 3 105) from poly(I:C)-injected Mx1-Cre/
p57+/+ or Mx1-Cre/p57+/F mice (CD45.2) competed against an
equal number of BM cells from C57BL/6 heterozygous congenic
mice (CD45.1/CD45.2) to reconstitute the hematopoietic
compartment of irradiated C57BL/6 congenic mouse (CD45.1)
recipients. At 16 weeks after BM cell transplantation (BMT),
flow cytometric analysis of peripheral blood of the recipients re-
vealed that the repopulating capacity of p57-deficient BM cells
was markedly impaired, whereas that of p21–/– or p27 –/– BM
cells did not differ from that of cells from littermate controls (Fig-
ure 2A). Given that this result might have reflected the reduced
number of HSCs in p57-deficient mice (Figures 1B and 1C), we
also performed similar assays with total KSL cells (1.5 3 103)
or CD150+CD48–KSL cells (2.0 3 102) isolated from p57-
deficient mice or littermate controls at 4 weeks after poly(I:C)
injection. The p57-deficient KSL cells showed a greatly impaired
repopulating capacity after the first BMT, and this impairment
was even more pronounced after a second BMT (Figures 2B
and 2C). In addition, the frequency of KSL cells derived from
p57-deficient donors among BM cells of the recipient mice
was markedly smaller than that for KSL cells derived from
control donors (Figure 2D). To determine whether p57 intrinsi-
cally regulates HSC repopulating capability, we transplanted
BM cells (43 105) from either Mx1-Cre/p57+/F mice or littermate
controls not treated with poly(I:C) into lethally irradiated recipi-
ents together with the same number of competitor cells. After
4 weeks, we confirmed that donor cells were reconstituted in
recipient BM and then injected the recipient mice with poly(I:C).
Within 1 month after poly(I:C) injection, p57-deficient HSCs lost
long-term repopulating capability andwere eventually competed
out by wild-type HSCs (Figure 2E), suggesting that a homing
defect of transferred BM cells probably was not responsible for
the impaired BM reconstitution by p57-deficient HSCs.Stem Cell 9, 262–271, September 2, 2011 ª2011 Elsevier Inc. 263
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Figure 1. Decrease in HSC Number Induced by p57 Deletion
(A) Immunoblot analysis (IB) of fractionated hematopoietic cells from BM of wild-type mice. For positive and negative controls, mouse embryonic fibroblasts
(MEFs) were cultured with or without 100 mM MG132, respectively.
(B) Flow cytometric determination of the frequency of KSL cells among BM cells of Mx1-Cre/p57+/+ and Mx1-Cre/p57+/F mice at 4 weeks after poly(I:C) injection.
The percentages of KSL cells among total BM cells are shown as means ± SD.
(C) Frequency of the indicated fractions among total BM cells from mice of the indicated genotypes. Mice harboring the Mx1-Cre transgene were examined at
4 weeks after poly(I:C) injection. Data are means ± SD. **p < 0.01, ***p < 0.005; NS, not significant.
See also Figure S1.
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Figure 2. p57, but Not p21 or p27, Is Essential for HSC Maintenance
(A) Hematopoietic reconstitution capacity of BM cells (43 105) from donor mice of the indicated genotypes. Cells from donors harboring the Mx1-Cre transgene
were harvested at 4 weeks after poly(I:C) injection. Data are means ± SD. ***p < 0.005.
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Role of p57 in Adult Hematopoietic Stem CellsWe further performed long-term culture of KSL cells on a layer
of OP9 stromal cells, with the number of colony-forming cells
arising after 2 or 5 weeks of culture reflecting the function of
hematopoietic progenitor or stem cells, respectively. The
number of colonies derived from p57-deficient KSL cells was
significantly decreased compared with that derived from control
cells, although a similar assay with freshly isolated KSL cells
without culture did not show a significant difference in the
number of colonies formed (Figure 2F). The number of colonies
derived from p21- or p27-deficient KSL cells did not differ signif-
icantly from that derived from the corresponding control cells
with or without culture on OP9 cells. A serial replating assay re-
vealed that the number of colonies derived from p57-deficient
KSL cells declined to a greater extent compared with that of
colonies derived from control cells with each plating, whereas
the number of colonies derived from p21- or p27-deficient KSL
cells did not differ significantly from that derived from the corre-
sponding control cells at each plating (Figure S2). Collectively,
these results suggested that the self-renewal capacity of HSCs
was profoundly affected by the loss of p57, but not by that of
p21 or p27.
p57 Is Required for Maintenance of Quiescence in HSCs
HSCs are normally maintained in an undifferentiated quiescent
(G0 phase) state, with this quiescence protecting the cells
against loss of self-renewal capacity. To evaluate directly HSC
quiescence in p57-deficient mice, we stained KSL cells from
poly(I:C)-injected Mx1-Cre/p57+/+ or Mx1-Cre/p57+/F mice with
a combination of Hoechst 33342 and pyronin Y, which differen-
tially and quantitatively stain DNA and RNA and thereby allow
detection of cells in G0 phase. We found that 28% of control
KSL cells were negative for staining with pyronin Y, indicative
of normal HSC quiescence, whereas only 15% of p57-deficient
KSL cells were in G0 phase (Figures 3A and 3B). No such differ-
ence was observed for p21- or p27-deficient KSL cells and the
corresponding control cells. We also examined the cell cycle
status of CD34–KSL and CD34+KSL cells on the basis of 5-bro-
modeoxyuridine (BrdU) incorporation. More BrdU+ cells were
detected among p57-deficient CD34–KSL and CD34+KSL popu-
lations than among the corresponding control cells (Figure 3C),
consistent with the reduced size of the G0 population for p57-
deficient KSL cells. Furthermore, the frequency of apoptosis
was substantially increased among p57-deficient KSL cells,
but not among p21- or p27-deficient KSL cells (Figure 3D).
Similar results were obtained 3 days after the onset of a short-
ened course of poly(I:C) treatment (Figures S3A–S3D). These
results thus suggested that p57, but not p21 or p27, is essential
for maintenance of HSC quiescence.(B and C) Hematopoietic reconstitution capacity of KSL cells (1.53 103) (B) or CD1
mice at 4 weeks after poly(I:C) injection. BM cells (23 106) from the recipient mice
SD. ***p < 0.005.
(D) Frequency of donor-derived KSL cells among total BM cells of recipient mice
(E) Irradiated recipient mice were transplanted with donor BM cells (4 3 105) from
with an equal number of competitor BM cells. The recipients were injected with p
cells in peripheral blood was determined. Data are means ± SD. ***p < 0.005.
(F) In vitro colony formation capacity of KSL cells frommice of the indicated genoty
Mx1-Cre transgene were harvested at 4 weeks after poly(I:C) injection. Data are
See also Figure S2.
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p53 was increased in p57-deficient KSL cells (Figures S3E and
S3F). Treatment of p57-deficient cells with the p53 inhibitor
pifithrin-a resulted in suppression of apoptosis and significant
restoration of their colony-forming ability (Figures S3G and
S3H). Phosphorylation of the retinoblastoma protein (Rb) was
increased in p57-deficient KSL cells compared with that in
control cells, whereas no such differencewas observed between
the c-Kit+Sca-1–Lin– populations of the two genotypes (Figures
3E–3G). Treatment of p57-deficient KSL cells with the chemical
CDK inhibitor SU9516, which is relatively specific for CDK2,
reversed, at least in part, the changes in colony-forming ability,
quiescence, and viability induced by loss of p57 (Figures 3H–3K),
suggesting that increased CDK activity contributes to these
effects of p57 deletion in KSL cells. Collectively, these results
indicated that the loss of p57 results in exhaustion of HSCs,
which is attributable in part to the induction of apoptosis medi-
ated by upregulation of CDK activity and p53 expression.
Functional Overlap of p57 with Other CKIs
Although our data indicated that p57 is a key CKI in the determi-
nation of stemness of HSCs, it remained possible that other CKIs
might partially compensate for the effects of p57 deficiency. To
examine this possibility, we generated double-mutant mice
that lack both p21 and p57 (Mx1-Cre/p21–/–/p57+/F mice injected
with poly(I:C)). Whereas deletion of p57 alone did not affect
colony-forming activity of KSL cells in vitro before coculture
with OP9 cells (Figure 2F), combined deletion of p21 and p57
resulted in a decrease in such colony formation (Figure 4A).
Furthermore, the size of individual colonies was markedly
smaller for the double mutant cells than for cells of poly(I:C)-in-
jected Mx1-Cre/p21+/+/p57+/+ or Mx1-Cre/p21+/+/p57+/F mice
(Figure 4B). The number of colonies formed after coculture
with OP9 cells was further decreased for the double-mutant
KSL cells compared with that for p57-deficient KSL cells (Fig-
ure 4C). However, no significant difference in the percentage of
cells in G0 phase or in the frequency of apoptosis was apparent
between KSL cells deficient in p57 alone and those deficient in
both p21 and p57 (Figures 4D and 4E). Together, these results
suggested that the combined deletion of both CKIs might affect
not only HSCs but also progenitor cells. We also examined HSC
function in mice lacking both p21 and p27. The number of colo-
nies formed, the percentage of cells in quiescence, and the
frequency of apoptosis did not differ significantly between KSL
cells derived from p21–/–/p27–/– mice and those derived from
wild-type mice (Figures S4A–S4C).
Whereas the members of the Cip/Kip family of CKIs (p21, p27,
p57) share a CKI domain that is essential for inhibition of CDKs,50+CD48–KSL cells (23 102) (C) derived fromMx1-Cre/p57+/F or control donor
in (B) were serially transplanted into additional recipient mice. Data aremeans ±
in (B) at 16 weeks after transplantation. Data are means ± SD. ***p < 0.005.
Mx1-Cre/p57+/+ or Mx1-Cre/p57+/F mice (not injected with poly(I:C)) together
oly(I:C) at 4 weeks after transplantation, and the percentage of donor-derived
peswith or without prior coculture with OP9 cells. Cells frommice harboring the
means ± SD. ***p < 0.005.
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Figure 3. Loss of Quiescence and Induction of Apoptosis due to Increased CDK Activity in p57-Deficient HSCs
(A) Frequency of quiescence in KSL cells of Mx1-Cre/p57+/+ and Mx1-Cre/p57+/F mice at 4 weeks after poly(I:C) injection. Quiescent cells were detected by
staining with Hoechst 33342 and pyronin Y followed by flow cytometry.
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Role of p57 in Adult Hematopoietic Stem Cellsp57 also contains a central domain that is absent in p21 and p27
and is thought to mediate functions other than inhibition of CDKs
(Matsuoka et al., 1995). To test whether p57 function in themain-
tenance of HSCs is replaceable by p27, we examined the BM of
p57p27KI mice, in which the p57 gene has been replaced with the
p27 gene (Susaki et al., 2009). Similar to the pattern of p57
expression in wild-type mice, HA-tagged p27 encoded by the
knockin allele at the p57 gene locus was expressed only in the
KSL fraction, not in other more differentiated cells (Figure 4F).
The size of the KSL population in p57p27KI mice was indistin-
guishable from that in wild-type mice (Figure 4G), and there
was no difference in repopulating capacity at the first BMT, in
colony formation in vitro with or without prior coculture with
OP9 cells, or in the frequency of quiescence or apoptosis
between HSCs of the two genotypes (Figures 4H–4K; Fig-
ure S4D). These results suggested that the total abundance of
CKIs of the Cip/Kip family is an important determinant of HSC
stemness.
DISCUSSION
We have examined the physiological importance of p57 in main-
tenance of HSCs by analysis of the effects of conditional deletion
of p57 in mouse hematopoietic cells. Such mice lacking p57
manifested a reduction in the size of the HSC fraction as well
as in the self-renewal capacity and G0 population of KSL cells,
effects that were not observed in mice lacking p21 or p27 (or
both). We thus conclude that p57 plays the dominant role among
Cip/Kip CKIs in the maintenance of HSCs.
The related CKIs p27 and p57 differ in the spatiotemporal
patterns of their expression in many tissues and organs (Naga-
hama et al., 2001). Whereas p57 is most abundant in the HSC
fraction of BM cells, its expression ceases as HSCs differentiate
into progenitor cells. Expression of p27 is apparent in all hema-
topoietic fractions, whereas p21 is not detected in such cells in
the absence of genotoxic stress. The expression patterns of
these CKIs appear consistent with the phenotypes of the corre-
sponding knockout mice. However, our present results suggest
the existence of functional overlap between p57 and its related
CKIs. The defects induced by p57 deficiency were thus reversed
by p27 knockin, suggesting that the function of these CKIs at the
molecular level is indistinguishable. We hypothesize that the
specific response of cells to the lack of each CKI might be(B) Quantitative analysis of quiescent cells among KSL cells from mice of the indic
means ± SD. ***p < 0.005.
(C) Frequency of proliferating cells among CD34–KSL and CD34+KSL cells isola
injection. Proliferating cells were detected by BrdU pulse-labeling analysis in viv
(D) Quantitative analysis of apoptotic cells among KSL cells from mice of the indic
with annexin V and propidium iodide (PI). Data are means ± SD. ***p < 0.005.
(E) Immunoblot analysis of phosphorylated Rb in KSL and c-Kit+Sca-1–Lin– ce
injection.
(F and G) Quantitative analysis of the relative amounts of Ser608-phosphorylate
similar to that in (E). Data are means ± SD. **p < 0.01, ***p < 0.005.
(H and I) Colony formation by KSL cells fromMx1-Cre/p57+/+ andMx1-Cre/p57+/F
(H) or 5 weeks (I) with 160 nM SU9516 or dimethyl sulfoxide (DMSO). Data are m
(J and K) Quantitative analysis of quiescent cells (J) and apoptotic cells (K) am
after culture for 2 weeks on OP9 cells, the second week in the presence of 1
are means ± SD. ***p < 0.005.
See also Figure S3.
268 Cell Stem Cell 9, 262–271, September 2, 2011 ª2011 Elsevier Independent on the total CKI abundance rather than on CKI
type, but further investigation will be necessary to confirm this
hypothesis. This relation between p27 and p57 in HSCs is similar
to that observed in most (but not all) other tissues examined
(Susaki et al., 2009).
Regulation of the cell cycle is thought to play a key role in the
maintenance and function of HSCs. Mutant mice with deletions
in genes for various cell cycle regulators thus manifest defects
in HSC maintenance and function. The numbers of HSCs as
well as common myeloid and lymphoid progenitors are
decreased in mice with conditional inactivation of cyclin A2 (Ka-
laszczynska et al., 2009). The reconstitution ability of BM cells is
also markedly impaired in these latter mutant mice. Likewise,
mice lacking all D-type cyclins (cyclins D1, D2, and D3) show
pronounced BM defects associated with a loss of the reconstitu-
tion capacity of BM cells; these animals develop severe anemia
and die in utero (Kozar et al., 2004). Similar defects are apparent
in mice deficient in both CDK4 and CDK6, which are the major
partners of D-type cyclins (Malumbres et al., 2004). In contrast,
no abnormality is apparent in mice lacking CDK2 (Berthet
et al., 2007), suggesting that CDK1 may compensate for the
loss of CDK2 (Aleem et al., 2005).
Rb is a major target of CDK2 and CDK4. Vav1-Cre/RbF/F mice,
which express Cre recombinase in hematopoietic cells, show a
marked defect in the self-renewal competence andmultipotency
of HSCs (Daria et al., 2008), and deletion of all members of the Rb
family (Rb, p107, and p130) further exacerbated this phenotype
(Viatour et al., 2008). Mice deficient in E2F1, E2F2, and E2F3,
all of which are downstream targets of Rb, show a decrease in
the number of myeloid cells but maintain the function of HSCs
(Viatour et al., 2008).
Some of the members of the Ink4 family of CKIs also con-
tribute to the regulation of HSCs. Expression of p16Ink4a in
HSCs increases with age, and the self-renewal capacity of
HSCs does not decline with age inmice deficient in this CKI (Jan-
zen et al., 2006). Mice lacking p15Ink4b do not exhibit an apparent
defect in HSC function, although the proliferation of progenitors
for granulocytes and monocytes is enhanced in these animals
(Rosu-Myles et al., 2007). Loss of p18Ink4c results in expansion
of the HSC pool associated with promotion of the cell cycle
without loss of self-renewal capacity (Yuan et al., 2004). The
effects of deletion of Ink4 CKIs thus appear opposite to those
of deletion of Cip/Kip CKIs. Deletion of Cip/Kip CKIs results inated genotypes as determined from experiments similar to that in (A). Data are
ted from Mx1-Cre/p57+/+ and Mx1-Cre/p57+/F mice at 4 weeks after poly(I:C)
o. The percentages of BrdU-positive cells are indicated as means ± SD.
ated genotypes. Apoptotic cells in the KSL fraction were detected by staining
lls from Mx1-Cre/p57+/+ and Mx1-Cre/p57+/F mice at 4 weeks after poly(I:C)
d Rb (F) and Ser780-phosphorylated Rb (G) as determined from experiments
mice at 4 weeks after poly(I:C) injection after coculture onOP9 cells for 2 weeks
eans ± SD. ***p < 0.005.
ong KSL cells from CAG-Cre-ERT2/p57+/+ and CAG-Cre-ERT2/p57+/F mice
mM 4-hydroxytamoxifen (4-OHT) and either 160 nM SU9516 or DMSO. Data
c.
A0
20
40
60
80
100
120
Co
lo
ny
 n
um
be
r
Mx1-Cre/p21+/+/p57+/+ (n = 3)
Mx1-Cre/p21-/-/p57+/F (n = 3)
Mx1-Cre/p21+/+/p57+/F (n = 3)
WT (n = 9)
p57p27KI (n = 8)
0
20
40
60
80
10
30
50
70
90
0
40
80
120
160
20
60
100
140
Co
lo
ny
 n
um
be
r
IH
Sca-1
c-
Ki
t
F
WT (n = 3)
p57p27KI (n = 3)
WT (n = 3) p57p27KI (n = 3)
0.144   0.013%+
-
0.146   0.017%+
-
NS NS NS
B
Mx1-Cre/p21+/+/p57+/+ Mx1-Cre/p21-/-/p57+/FMx1-Cre/p21+/+/p57+/F
Lin- gated Lin- gated
D
on
or
-d
er
ive
d 
ce
lls
 (%
)
NS
(-) 2
(weeks)
Prior culture with OP9 cells
5
Mx1-Cre/p21+/+/p57+/+ (n = 3)
Mx1-Cre/p21-/-/p57+/F (n = 3)
Mx1-Cre/p21+/+/p57+/F (n = 3)
0
5
10
15
20
25
30
35
KS
L 
ce
lls
 in
 G
0 
ph
as
e 
(%
)
0
0.5
1.0
1.5
2.0
2.5
3.0
An
ne
xin
 V
+
/P
I-  
ce
lls
 in
 K
SL
 ce
lls
 (%
)
D E
KJ
0
5
10
15
20
25
30
35
KS
L 
ce
lls
 in
 G
0 
ph
as
e 
(%
)
40
0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
WT (n = 3)
p57p27KI (n = 3)
WT (n = 3)
p57p27KI (n = 3)
An
ne
xin
 V
+
/P
I-  
ce
lls
 in
 K
SL
 ce
lls
 (%
)NS NS
Mx1-Cre/p21+/+/p57+/+
 (n = 3)
Mx1-Cre/p21-/-/p57+/F
 (n = 3)
Mx1-Cre/p21+/+/p57+/F
 (n = 3)
2
(weeks)
Prior culture with OP9 cells
5
0
40
80
120
160
20
60
100
140
Co
lo
ny
 n
um
be
r
C Mx1-Cre/p21+/+/p57+/+ (n = 3)
Mx1-Cre/p21-/-/p57+/F (n = 3)
Mx1-Cre/p21+/+/p57+/F (n = 3)
140
IB: p27
IB: p57
IB: β-actin
W
T
p5
7
p2
7K
I
W
T
p5
7
p2
7K
I
W
T
p5
7
p2
7K
I
W
T
p5
7
p2
7K
I
KSL     c-Kit
+
Sca-1-Lin- Lin- Lin+
G
Endo.
KI
***
***
***
NS
***
NS
NS
***
NS
***
Figure 4. Overlap of CKI Function in HSC Maintenance
(A) In vitro colony formation capacity of KSL cells from mice of the indicated genotypes at 4 weeks after poly(I:C) injection. Data are means ± SD. ***p < 0.005.
(B) Representative colonies from the experiment shown in (A). Scale bars represent 0.5 mm.
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Cell Stem Cell
Role of p57 in Adult Hematopoietic Stem Cellsexit of HSCs from the quiescent state and their entry into the
proliferation cycle, an effect that is associated with the loss of
self-renewal capacity or promotion of differentiation (or both).
The direct downstream targets of p27 and p57 CKIs are
thought to be CDK2 and CDK4 (or CDK6), and inhibition of
CDK activity by these CKIs maintains Rb in the unphosphory-
lated state (Halaban, 2005). Our results now show that the phos-
phorylation of Rb on Ser608 (phosphorylated by CDK2-cyclin
A or E and CDK4-cyclin D) and Ser780 (phosphorylated by
CDK4-cyclin D) (Halaban, 2005) was increased in p57-deficient
KSL cells, suggesting that the activity of CDK2 or CDK4 (or
both) is increased in KSL cells by deletion of p57.
We examined whether the effects of p57 deletion in HSCs are
reversed by inhibition of CDK activity with the use of the chemical
CDK inhibitor SU9516, which is relatively specific for CDK2
(Moshinsky et al., 2003). The in vitro colony formation capacity
of KSL cells from poly(I:C)-injected Mx1-Cre/p57+/F mice was
partially restored by treatment with SU9516 during prior cocul-
ture with OP9 cells, suggesting that increased activity of CDK2
is probably responsible for the effects of p57 deletion in KSL
cells. The partial, rather than complete, restoration might be
attributable to a contribution of CDK4 to the downregulation of
colony formation ability in the p57-deficient KSL cells.
We have also shown that treatment of p57-deficient KSL cells
with the p53 inhibitor pifithrin-a suppressed apoptosis and
partially restored colony-forming ability. Furthermore, we have
independently demonstrated that ablation of p57 results in hy-
peractivation of E2F1 and consequent p53-mediated apoptosis
in mice (Susaki et al., 2009). Together, these lines of evidence
support the notion that p57 deficiency results in abnormal upre-
gulation of CDK activity, leading to hyperactivation of E2F1 and
the triggering of p53-dependent apoptosis.
One of the substantial differences between fetal and adult
HSCs is their dependency on quiescence: Maintenance of
quiescence is thus thought to be more important for adult
HSCs than for fetal HSCs. In an accompanying paper (Zou
et al., 2011 [this issue of Cell Stem Cell]), HSCs in the fetal liver
of conventional p27- or p57-deficient mice (Nakayama et al.,
1996; Takahashi et al., 2000) were analyzed. Fetal HSCs lacking
p57 did not manifest an apparent defect with the exception of a
slight decrease in BM reconstitution capacity that was observed
only after the third round of BM transfer. Combined deletion of
p27 and p57 resulted in a marked failure in the maintenance of
fetal HSCs, however, suggesting that these two CKIs have
redundant roles. In contrast, our present study shows that p57
deficiency alone results in a substantial decrease in the number
of adult HSCs as a result of their exit from quiescence and entry
into apoptosis, with the BM reconstitution capacity of these(C) In vitro colony formation capacity of KSL cells from mice of the indicated gen
(D and E) Quantitative analysis of quiescent cells (D) and apoptotic cells (E) am
***p < 0.005.
(F) Immunoblot analysis of fractionated hematopoietic cells from BM of wild-type
knocked-in hemagglutinin epitope-tagged p27 (KI) are shown.
(G) Frequency of KSL cells among BM cells of wild-type and p57p27KI mice. The
(H) Hematopoietic reconstitution capacity of BM cells from p57p27KI and litterma
(I) In vitro colony formation capacity of KSL cells from wild-type and p57p27KI mic
(J and K) Quantitative analysis of quiescent cells (I) and apoptotic cells (J) among
See also Figure S4.
270 Cell Stem Cell 9, 262–271, September 2, 2011 ª2011 Elsevier Inp57-deficient cells also being greatly reduced from the first
round of BM transfer. Deletion of p21 or p27 (or both proteins)
did not result in any overt abnormalities in adult HSCs. Our
analysis of mice lacking both p21 and p57 suggests that p21
also contributes to the maintenance of hematopoiesis, and
that of p57p27KI mice suggests that p57 function in HSC mainte-
nance can be replaced by p27. Collectively, our present study
demonstrates that p57 plays a predominant role in constitutive
maintenance of HSCs after birth.EXPERIMENTAL PROCEDURES
Mice
Detailed methods for the generation of mice heterozygous for the floxed p57
allele (p57+/F mice) as well as other mice used in this study are described in
Supplemental Experimental Procedures. All mice were backcrossed with
C57BL/6 mice more than six times. All mouse experiments were approved
by the animal ethics committee of Kyushu University.BM Reconstitution Assays
Unfractionated BM cells (4 3 105), sorted LSK cells (1.5 3 103), or sorted
CD150+CD48–LSK cells (2 3 102) from p21–/–, p27–/–, Mx1-Cre/p57+/F, or
corresponding littermate control mice (CD45.2) were transplanted into lethally
irradiated C57BL/6 congenic (CD45.1) recipients together with competitor BM
cells (4 3 105) from C57BL/6 heterozygous congenic (CD45.1/CD45.2) mice.
For serial transplantation analysis, BM cells (2 3 106) were obtained from
recipient mice at 16 weeks after transplantation (first BMT) and were trans-
ferred to a second set of lethally irradiated mice (second BMT).Colony Formation Assays
Sorted KSL cells were subjected to colony formation assays with or without
prior coculture with OP9 cells. Detailed methods for the assays are described
in Supplemental Experimental Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at doi:10.1016/
j.stem.2011.06.014.ACKNOWLEDGMENTS
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